James W Kazura is an expert in Infectiology at Case Western Reserve University (United States). As of July 2026, ScienceLeadR ranks James W Kazura in the top 1% of experts worldwide for Mosquito-Borne Diseases. James W Kazura has authored 331 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,373 (community average: 125). How the SLR is computed.

LeadR Profile

James W Kazura Case Western Reserve University United States
1 373 ScienceLeadR Reputation 1373
Network Map

Infectiology

Subspecialties: Genetics - Hematology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Case Western Reserve University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 331

Citations

Citations: 12 415 1st author: 23 Last author: 97 Unique author: 16


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Benchmarking of real-time, field-deployable whole-genome sequencing of Plasmodium falciparum using Nanopore technology.
PMID 42525447 — malaria, genomics, whole genome sequencing, genome, parasites, benchmarking, infections, nanopores, drug resistance
Microb Genom20260
Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.
PMID 42446942 — malaria, cerebral, malaria, kallikreins, brain, brain edema, bradykinin, artesunate, edema, child, plasma
J Clin Invest20260
Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria.
PMID 42124709 — malaria, cerebral, malaria, kallikreins, brain, brain edema, central nervous system, bradykinin, nervous system, artesunate, edema, child, plasma
bioRxiv20260
Adaptive intervention strategies for malaria vector control in western Kenya: a cluster, sequential, multiple-assignment, randomised, open-label trial.
PMID 42044656 — malaria, incidence, global health, drug-related side effects and adverse reactions
Lancet Glob Health20260
The hidden malaria: Misidentification of Plasmodium malariae and Plasmodium ovale in low-transmission setting targeted for elimination in Ethiopia.
PMID 41994136 — malaria, polymerase chain reaction, signs and symptoms, microscopy, prevalence, health facilities, infections
Res Sq20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 3
Phase 2 1
Phase 3 1

By status:

Completed 4
Active not recruiting 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map